The global demand for Colorectal Cancer Screening Market is presumed to reach the market size of nearly USD 36.83 BN by 2028 from USD 25.66 BN in 2021 with a CAGR of 5.3% under the study period 2022 - 2028.
Colorectal or colon cancer, is a type of which is located in the large intestine (colon). Colorectal Cancer (CRC) screening is an effective way to detect the disease early when it is most treatable. Screening methods include Fecal Occult blood tests (FOBT and FIT), stool DNA tests, sigmoidoscopy, and colonoscopy. Colonoscopy is the most sensitive screening test, an invasive procedure recommended for people at average or high risk of colorectal cancer.
Market Dynamics
The increasing prevalence of colorectal cancer has led to increased demand for screening and early detection of the
disease. Moreover, the benefits of early detection of CRC have raised awareness about the importance of screening. The increase in the ageing population is also driving the demand for colorectal cancer screening. Furthermore, the global colorectal cancer screening market is expected to see significant growth due to advancements in technology for screening. However, the high cost of screening is expected to impede the growth of the global colorectal cancer screening market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of colorectal cancer screening. The growth and trends of colorectal cancer screening industry provide a holistic approach to this study.
Market Segmentation
This section of the colorectal cancer screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Screening Tests
- Stool-Based Tests
- Colonoscopy
- CT Colonography (Virtual Colonoscopy)
- Flexible Sigmoidoscopy
- Other Screening Tests
By End User
- Hospitals Independent Diagnostic Labs
- Other End Users
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Colorectal Cancer Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Colorectal Cancer Screening Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the colorectal cancer screening market include Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, and Clinical Genomics Technologies Pty Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.